Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi 465-8603, Japan Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural ...

Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade ...

Researchers at Fred Hutchinson Cancer Center, led by Dr. Julie McElrath, Director of the Vaccine and Infectious Disease Division, have found a new way to train our immune system to make antibodies ...

Deciding on antigen vs. antibody tests when choosing a COVID-19 test is easier when the definitions and their function are clear. These tests represent different ways you can check for SARS-CoV-2, the ...

This is because some drugs work in more than one way and belong to more than one group. Checkpoint inhibitors are also described as a type of monoclonal antibody or targeted treatment. Our immune ...